The transplant of older poop actually seemed to boost the health of their ovaries. Consistently, young mice that received ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

Immorta Bio Inc., a scientific longevity biotechnology company dedicated to Treating Diseases of Aging and Treating Aging as Disease™, today announced breakthrough preclinical results demonstrating ...

UAB researchers report that the oral drug TIX100 prevented weight regain after stopping semaglutide in preclinical studies. The findings suggest a potential non‑GLP‑1 therapy to maintain weight loss ...

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

TIX100 is a specific, orally available TXNIP inhibitor originally developed for its beta-cell protective effects in diabetes. It has received FDA Investigational New Drug approval in diabetes and ...

When the eye’s drainage system clogs, intraocular pressure (IOP) builds up and causes damage. The pressure can lead to glaucoma and vision loss. Researchers headed by a team at Duke University School ...

A recent study in Translational Psychiatry shows that one dose of DMT reversed loss of pleasure and cognitive deficits in stressed mice. The psychedelic promoted new brain cell growth, highlighting ...

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...

Performance-enhancing peptides are increasingly popular among fitness enthusiasts and biohackers, despite limited human ...